Searchable abstracts of presentations at key conferences in endocrinology

ea0049gp141 | Female Reproduction | ECE2017

Effects of central sympathoinhibition with moxonidine on the elevated sympathetic nervous activity and downstream metabolic abnormalities observed in polycystic ovary syndrome

Shorakae Soulmaz , Lambert Elisabeth , Jona Eveline , Sari Carolina Ika , de Courten Barbora , Lambert Gavin , Teede Helena

The role of the sympathetic nervous system (SNS) in the pathophysiology of PCOS and associated cardiometabolic risks is emerging. Previous studies support increased SNS activity in PCOS, potentially contributing to metabolic features via multiple mechanisms including insulin resistance. Moxonidine is a second-generation imidazoline I1 agonist, acting centrally, inhibiting sympathetic outflow at the level of rostral ventrolateral medulla with known beneficial effects...

ea0049ep98 | Adrenal medulla | ECE2017

Pheochromocytoma – surgical outcomes

Martins Pedro Carvalho , Ribeiro Catia , Peyroteo Mariana , Pereira Helena , de Sousa Abreu

Objective: To retrospectively evaluate the results of the pheochromocytoma surgery in our institution assessing the surgical complications, perioperative hemodynamic instability and oncologic outcomes.Methods: The medical records of patients admitted for pathologically confirmed pheochromocytoma between 2000 and 2015 were reviewed. Patients with paragangliomas were excluded.Results: We identified 40 patients with 43 resected pheoch...

ea0049ep562 | Diabetes complications | ECE2017

Biomarkers status and their relation with the presence of type 2 diabetes with and without angiopathy

Valente Ana , Bicho Manuel , Duarte Rui , Raposo Joao , Costa Helena Soares

Introduction: A useful tool for disease clinical characterization and treatment of type 2 diabetes is the knowledge on the status of several biomarkers. The aim of this study was to evaluate the levels of cardiovascular, oxidative stress and nutritional biomarkers and their relationship with the presence of type 2 diabetes and angiopathy.Methods: A population-based case-control study in 150 Portuguese type 2 diabetic patients was performed. Group I &#150...

ea0049ep818 | Paediatric endocrinology | ECE2017

Turner Syndrome (TS): overview of surveillance in a tertiary care hospital

Popik Ekaterina , Matos de Figueiredo Catarina , Freitas Joana , Cardoso Helena , Joao Oliveira Maria , Borges Teresa

Introduction: Turner syndrome is one of the most common human chromosomopathy and represents an important cause of short stature and ovarian insufficiency. It is caused by total or partial loss of X-chromosome and its prevalence is about 1 in 2000–2500 live female births.Objectives: To review the patients with TS followed in a Paediatric Endocrinology Unit since 1999.Methods: A retrospective study regarding diagnosis, course, ...

ea0049ep921 | Neuroendocrinology | ECE2017

Kallmann syndrome: about eleven clinical cases

Fonseca Liliana , Amaral Claudia , Dores Jorge , Palma Isabel , Carvalho Rui , Cardoso Helena , Vilaverde Joana , Borges Fatima

Idiopathic congenital hypogonadotropic hypogonadism (CHH) is a rare reproductive disorder that is primarily caused by a gonadotrophin-realising hormone (GnRH) deficiency. When CHH is associated with hyposmia or anosmia is designated by Kallmann Syndrome (KS). This syndrome is a genetic disorder with significant genetic heterogeneity that may present as a sporadic or familial case, following autosomal dominant, autosomal recessive, or X – linked recessive modes of inherita...

ea0049ep923 | Paediatric endocrinology | ECE2017

Growth hormone deficiency – the experience of one pediatric endocrinology unit of a Portuguese hospital in the last 5 years

Ferreira Jorge Abreu , Barroso Fabio , Martins Cristiana , Freitas Joana , Cardoso Helena , Oliveira Maria Joao , Borges Teresa

Introduction: Hypopituitarism is a clinical syndrome of deficiency in growth hormone (GHD) production, which can occur isolated or associated with others pituitary defects. GHD has an incidence of 1:4000 to 1:10 000. It may be idiopathic, congenital or acquired.Purpose: Characterize the paediatric population with GHD followed at the Paediatric Endocrinology Unit of our centre and compare the clinical presentation and treatment response of the patients wi...

ea0049ep1052 | Pituitary - Clinical | ECE2017

Ipilimumab induced hypophysitis – an insight from a case series in the United Kingdom

Kempegowda Punith , Quinn Lauren , Vijayan Melapatte Anitha , Jain Ankit , Steven Neil , Gleeson Helena , Toogood Andrew

Aims: To assess the incidence of Ipilimumab associated hypophysitis and its common presentations.Methods: All patients who developed Ipilimumab induced hypophysitis following treatment for Malignant melanoma at a large tertiary care centre in West Midlands, United Kingdom from 2012 to 2014 were included in the study. Patients with known pituitary disease prior to treatment and/or received other systemic immunotherapy following Ipilimumab treatment were e...

ea0049ep1387 | Thyroid (non-cancer) | ECE2017

Calcitonin: clinical and laboratory evaluation in a tertiary hospital

Silvestre Catarina , Bugalho Maria Joao , Sampaio Joaquim , Proenca Helena , Carvalho Raquel

Background: Calcitonin is a hormone secreted by thyroid C cells, and is considered an excellent marker for medullary thyroid carcinoma (MTC). However, the use of calcitonin to screen patients with nodular thyroid disease (NTD) remains controversial.Objective: Defining the frequency of hypercalcitoninemia among NTD patients followed at a tertiary referral hospital.Methods: Retrospective analysis of basal calcitonin measurements and ...

ea0046p7 | (1) | UKINETS2016

Evaluation of quality of life after each cycle in patients treated with Peptide Receptor Radionuclide Therapy (PRRT)

Mateo-Vito Ivy , Amlani Ashik , Leshen Rebelidad , Mcmeekin Helena , Davis Neil , Navalkissoor Shaunak

Background: NET-related symptoms such as flushing and diarrhoeas as well as disease related worries reduce quality of life in patients with neuroendocrine tumours (NETs). Peptide receptor radionuclide therapy (PRRT) is an established treatment in NETs and has been shown to prolong survival. However quality of life data post PRRT is lacking.Aim: To evaluate the symptoms prevalence, intensity and their relation to quality of life in patients receiving PRRT...

ea0043oc20 | Design a Clinical Program for Success | WCTD2016

Selected adipokines in patients with type 2 diabetes: relationship to markers of vascular damage

Karasek David , Gajdova Jaromira , Kubickova Veronika , Cibickova Lubica , Krystynik Ondrej , Vaverkova Helena

Introduction: Adiponectin, adipocyte fatty acid-binding protein (A-FABP), fibroblast growth factor 21 (FGF-21), C1q/TNF-related protein 9 (CTRP9) and allograft inflammatory factor-1 (AIF-1) belong to the proteins produced by adipocyte tissue, which differently contribute to oxidative stress, chronic inflammation, insulin resistance and endothelial damage. The aim of this pilot study was to compare their levels in patients with diabetes and in healthy individuals and determine ...